Meningococcal vaccine market primed for growth; Biothera wins NIH grant for fungal vaccine;

> The global meningococcal vaccines market is set to grow at a CAGR of 15% by 2018, a new reports says. More

> The NIH has awarded Minnesota-based Biothera a $150,000 research grant for fungal vaccine development. Release

> Cancer vaccine maker OncoPep Inc. has raised $6.9 million in Series B financing from new and existing investors. Release

> Madison Vaccines' lead product candidate will be used in a clinical trial testing a two-pronged immunotherapy approach to treat metastatic prostate cancer. Release

 

And Finally... Sekunjalo Investment Holdings and Genius Biotherapeutics have partnered to develop therapeutic vaccines for cancer in South Africa. Report

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

As a new coronavirus spreads, vaccine researchers have started work on candidates against the virus—and one could enter the clinic in a few months.

Merck's HPV vaccine Gardasil is delivering blockbuster sales as demand surges. But high demand has caused somewhat of a supply constraint.